Abstract
Background: One in three women who have a prolapse operation will go on to have another operation, though not necessarily in the same compartment. Surgery can result in greater impairment of quality of life than the original prolapse itself (such as the development of new-onset urinary incontinence, or prolapse at a different site). Anterior and posterior prolapse surgery is most common (90 % of operations), but around 43 % of women also have a uterine (34 %) or vault (9 %) procedure at the same time. There is not enough evidence from randomised controlled trials (RCTs) to guide management of vault or uterine prolapse. The Vault or Uterine prolapse surgery Evaluation (VUE) study aims to assess the surgical management of upper compartment pelvic organ prolapse (POP) in terms of clinical effectiveness, cost-effectiveness and adverse events.
Original language | English |
---|---|
Pages (from-to) | 441 |
Number of pages | 18 |
Journal | Trials |
Volume | 17 |
Early online date | 8 Sep 2016 |
DOIs | |
Publication status | Published - Sep 2016 |
Keywords
- pelvic organ prolapse
- randomised controlled trials
- study protocol